Perceptive Advisors LLC Adaptimmune Therapeutics PLC Transaction History

Perceptive Advisors LLC

  • $3.46 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$4.9 - $6.83 $1.96 Million - $2.73 Million
-400,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.58 - $12.1 $1.03 Million - $4.84 Million
400,000 New
400,000 $4 Million
Q3 2018

Nov 14, 2018
SELL
$8.27 - $13.56 $407,727 - $668,535
-49,302 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$10.42 - $13.74 $513,726 - $677,409
49,302 New
49,302 $585,000

Others Institutions Holding ADAP

# of Institutions
80
Shares Held
152M
Call Options Held
78.5K
Put Options Held
36.5K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $121M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email